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Introduction: Interface choice is crucial for non-invasive ventilation (NIV) success. We compared a new interface,
the helmet next (HN), with the facial mask (FM) and the standard helmet (HS) in twelve healthy volunteers.
Methods: In this study, five NIV trials were randomly applied, preceded and followed by a trial of unassisted
spontaneous breathing (SB). Baseline settings, for example, 5 cmH2O of both inspiratory pressure support (PS)
and positive end-expiratory pressure (PEEP), were applied through FM, HS and HN, while increased settings (PS and
PEEP of 8 cmH2O) were only applied through HS and HN. We measured flow, airway, esophageal and gastric pressures,
and calculated inspiratory effort indexes and trigger delays. Comfort was assessed with a visual-analog-scale.
Results: We found that FM, HS and HN at baseline settings were not significantly different with respect to inspiratory
effort indexes and comfort. Inspiratory trigger delay and time of synchrony (TI,synchrony) were significantly improved
by FM compared to both helmets, whereas expiratory trigger delay was shorter with FM, as opposed to HS only. HN
at increased settings performed better than FM in decreasing inspiratory effort measured by pressure-time product
of transdiaphragmatic pressure (PTPdi)/breath (10.7 ± 9.9 versus 17.0 ± 11.0 cmH2O*s), and PTPdi/min (128 ± 96 versus
204 ± 81 cmH2O*s/min), and PTPdi/L (12.6 ± 9.9 versus 30.2 ± 16.8 cmH2O*s/L). TI, synchrony was inferior between
HN and HS at increased settings and FM.
Conclusions: HN might hold some advantages with respect to interaction and synchrony between subject and
ventilator, but studies on patients are needed to confirm these findings.
Trial registration: ClinicalTrials.gov NCT01610960Introduction
The choice of the interface is one of the crucial factors
determining the success of noninvasive ventilation (NIV)
in both the acute [1] and chronic [2] setting. Different
types of face mask (FM) that is, oral, nasal, oronasal, total
full face of different size, design, and material are available
to increase the patient’s comfort. Despite the broad
availability of FMs, most NIV failures are still associated
with mask-related side effects such as air leaks [3], skin
breakdown [4,5], and mask discomfort [1,2,6].* Correspondence: s-jaber@chu-montpellier.fr
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reproduction in any medium, provided the orNew interfaces have been introduced with the aim of
improving patient comfort and overcoming these side
effects. The helmet is a transparent latex-free polyvi-
nylchloride hood; in its standard configuration it is joined
by a rigid plastic ring to a soft collar and secured by two
padded armpit braces at four hooks (two in the front
and two in the back of the plastic ring). The standard
helmet (HS) has been shown to improve NIV comfort
over time compared to FM and to reduce skin breakdown,
gastric distension, and eye irritation [7,8]. Despite these
advantages, the helmet has specific drawbacks primarily
related to its highly compliant soft collar [9]. Inspiratory
pressure dissipation increases the time lag between inspira-
tory effort and ventilator assistance, worsening patient
ventilator synchrony [10-12]. Furthermore, compared toral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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less efficient inspiratory-muscle unloading, both in healthy
volunteers [11] and patients [10,12]. In addition, the
armpit braces that maintain the helmet in place may
cause patients discomfort and skin lesions leading to
NIV intolerance and failure [13].
To reduce these technical problems, a new helmet (HN)
(NIV-Castar R Next, Starmed, Mirandola, Italy) has been
developed and introduced into clinical use, in which an
opening ring placed underneath an inflatable cushion
secures the helmet without the need for armpit braces.
Moreover, compared to HS, with HN the pressure dissi-
pated because of the downward displacement of the soft
collar during ventilator insufflation is eliminated, or at least
reduced to a large extent. Very recently a bench study
comparing HS and HN suggested a better performance of
the latter in terms of triggering performance, patient-
ventilator synchrony, and rate of pressurization [14].
The rotational use of different interfaces has been pro-
posed to improve patients’ tolerance and prolong NIV
application both in hypoxemic [15] and hypercapnic [16]
patients. On one hand, patients needing several daily
hours of NIV may benefit from the rotational use of
different interfaces to reduce the risk of discomfort and
the side effects of one specific interface [15-17]; on the
other hand, the use of diverse interfaces with equal
ventilator assistance may result in a different extent of
muscle unloading and patient-ventilator synchrony [10,12].
To overcome the decreased efficacy of the HS in delivering
ventilator assistance, compared to the FM, Vargas et al.
recently proposed to increase the level of both positive
end-expiratory pressure (PEEP) and inspiratory pressure
support (PS) [12].
The objective of this physiologic study was to assess
and compare the efficacy of FM, HS, and HN in delivering
NIV in healthy volunteers. Interaction and synchrony
between subject and ventilator, and the subject’s inspira-
tory effort and comfort were compared at baseline
settings, that is, at PEEP 5 cmH2O and PS 5 cmH2O,
and at increased settings, that is, PEEP 8 cmH2O and
PS 8 cmH2O.
Materials and methods
The protocol was approved by the institutional review
board (Comité de Protection des Personnes Sud Méditéra-
née IV, Montpellier; approval number 2012-A00098-35),
and written informed consent was obtained from each
subject. Twelve healthy volunteers were studied in a
semi-recumbent position. The subjects (three women
and nine men, age 30 ± 9 years) were all nonsmokers and
had a body mass index of 24 ± 4 kg/m2. NIV was delivered
trough an FM (Performatrak, Philips Respironics), HS
(NIV-Castar R), and HN (NIV-Castar R Next), using an
ICU ventilator equipped with software for air-leakscompensation (NIV module) (Servo-I, Maquet, Solna,
Sweden) set in PS ventilation mode.
Measurements
Airflow was measured with a pneumotachograph (Fleish
no. 2; Fleisch, Lausanne, Switzerland) connected to a
differential pressure transducer (MP45, ± 2 cmH2O;
Validyne, Northridge, CA, USA). The pneumotachograph
was placed between the mask inlet and the Y-piece of the
ventilator circuit during FM, and distally to the mouth-
piece during both spontaneous breathing and helmet
ventilation as shown in Figure 1. Tidal volume (VT)
was obtained by digital integration of the flow signal.
Pressure at the airway opening (Pao) was assessed via a
side port connected to a pressure transducer. Esophageal
(Pes) and gastric (Pga) pressures were measured using a
double balloon-tipped catheter (Nutrivent, Sidam s.r.l.,
Mirandola, Italy) positioned in the mid-esophagus and in
the stomach and connected to two differential pressure
transducers. The esophageal and gastric balloons were in-
flated with 4 ml of air. The correct positioning of the
esophageal balloon was checked by an inspiratory occlu-
sion [18]. Adequate placement of the gastric balloon
was ascertained by gentle manual pressure on the sub-
ject’s abdomen to observe fluctuations in gastric pressure,
as well as by asking the patient to swallow and verifying
that the sharp increase in the esophageal pressure caused
by esophageal contraction was not observed on the Pga
tracing. Transdiaphragmatic (Pdi) pressure was obtained
by subtracting Pes from Pga.
Patient’s own (neural) respiratory rate (RRn) and ventila-
tor rate of cycling (RRv) were determined from Pdi and
Pao swings, respectively. In line with previous studies
[10,11,19,20], the patient’s inspiratory time (TI,p) was esti-
mated from the Pdi tracing as the time between the onset
of the positive Pdi swing above baseline (that is, the start
of inspiratory effort) and the point where Pdi started to fall
toward baseline. Likewise, the duration of the inspiratory
assistance provided by the ventilator (TI,v) was calculated
from the Pao tracing. The inspiratory trigger delay (Delay,
TR-insp) was calculated as the time lag between onset of
inspiratory effort and start of ventilator support, and the
expiratory trigger delay (Delay,TR-exp) was calculated as
the time lag between the points at which Pdi and Pao
started to fall toward baseline. We also calculated the time
of synchrony between muscle effort and ventilator support
(TI,p-TI,v synchrony) as the period in the course of in-
spiration during which the diaphragm was contracting
and the ventilator was concurrently delivering support.
The pressure-time product of the transdiaphragmatic
(PTPdi) pressure was assessed to determine the effort
exerted by the diaphragm and to provide a surrogate
estimate of the overall inspiratory muscle exertion,
not considering the amount of effort spent to distend
Figure 1 Schematic representation of the experimental design. (A) Spontaneous breathing; (B) face mask; (C) helmet standard; (D) helmet
next. Pao, pressure at the airway opening; Pes, esophageal pressure; Pga, gastric pressure.
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pressure-time product was calculated per minute, deter-
mining the area under Pdi (PTPdi/min) within a 1-minute
time interval, per breath (PTPdi/br), dividing PTPdi/min
by RRn, and per liter, dividing PTPdi/min by minute
ventilation (VE) [10,12,21].
The inspiratory work of breathing (WOB) performed
by the patient was computed from Pes and VT loops as
previously described [22,23]. Briefly, the inspiratory work
per breath was calculated from the Campbell diagram by
computing the area enclosed between the inspiratory
esophageal pressure-VT curve on the one hand, and the
static esophageal pressure-volume curve of the chest
wall on the other hand, using a theoretical value for
chest-wall compliance (4% of the predicted value of the
vital capacity per cm H2O). Although we directed careful
attention to minimizing leaks around the mask, this
problem did occur and was taken into consideration.
Because leaks around the mask are more likely to occur
during inspiration, leading to overestimation of the inspired
volume, we calculated inspiratory WOB by applying a
correction factor to the inspiratory flow based on the
patient’s expired minute volume [23,24]. For this, we
measured the ratio of expired over inspired minute
volume and applied a correction factor equal to this
ratio to the flow signal used to measure inspiratory
WOB. Inspiratory WOB was expressed as the work per
breath (J/breath), as the work per volume unit (J/L),
and as the work per time unit (J/min).Comfort was assessed at the end of each trial, using a
0- to 10-item visual analog scale [25,26] (0 = intolerable
discomfort, 3 = strong discomfort, 8 =moderate discomfort,
10 = no discomfort). Heart rate and pulse arterial oxygen
saturation were monitored throughout the protocol.
Experimental protocol
A trial of spontaneous unassisted breathing (SB) was per-
formed in all subjects at the beginning of the study
protocol (SBI), followed by three NIV trials with FM, HS,
HN at baseline settings (PEEP and PS set at 5 cmH2O) and
two additional trials with the increased settings (PS and
PEEP set at 8 cmH2O) for HS and HN only. In all five NIV
conditions, each period lasted 5 minutes. The interfaces
were randomly applied following a computer-generated
random sequence. Once the interface was determined a
second computer-generated random sequence was applied
to establish the setting. To conclude, a second trial of
spontaneous unassisted breathing was performed (SBE).
A schematic representation of the experimental setup used
during unassisted spontaneous breathing, FM, HS and HN
ventilation is shown in Figure 1, and the new helmet is
depicted in detail in Figure 2.
The ICU ventilator Servo-i was set in NIV mode with
an inspired oxygen fraction (FiO2) of 21%, the fastest rise
time, an inspiratory trigger at five units, corresponding
to one l/minute, and cycling-off flow threshold of 25%
of the peak inspiratory flow. These last settings were
maintained unmodified throughout the study.
Figure 2 Helmet next. The new helmet (Helmet next) is composed
of a rigid plastic ring (1), inflatable cushion (2) with its inflating line
(3), anular opening ring secured to the rigid ring underneath the
cushion (4), and transparent hood (5). The helmet is secured to the
head by the inflated cushion placed around the neck below the jaw.
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a nose clip and breathed through a mouthpiece connected
to a side port connector for the measurement of the pres-
sure at the airway opening, and to a pneumotachograph.
The measuring equipment had a dead space of 49 ml and
resistance of 2.0 and 2.6 cmH2O L
-1 s-1 at a flow rate of
0.5 and 1.0 L/s, respectively.Data analysis
After elimination of cycles contaminated by artifacts
due to cough and esophageal spasms, 20 consecutive
breaths, closest to the end of the 5-minute run, were
used to compute average values. All observations were
included in the analysis. The signals were amplified,
low-pass filtered, digitized at 128 Hz and sampled using
an analog-to-digital converter system (MP100; Biopac
Systems, Santa Barbara, CA, USA). Results are expressed
as means ± SD and as group-mean difference ± SD. Nor-
mality of quantitative variables (Shapiro-Wilk test) was
checked. Data were compared using a generalized lin-
ear mixed-effects model for repeated measures, taking
into account repeated measures as random effects,
and NIV condition, cross-over sequence and its in-
teraction as fixed effects. Normality of residuals was
checked after applying the linear mixed-effects model.
Comparisons defined a priori were FM versus HS, FM
versus HN, SBI versus HS, and SBI versus HN. Signifi-
cance was set at P <0.0125 after correction using the
Bonferroni t-test for the number of multiple comparisons,
that is, four.Results
Vital signs and comfort
No subjects asked to discontinue the trial for any reason.
Heart rate and pulse arterial oxygen saturation remained
unchanged, regardless of interface and ventilator setting
(data not shown). Increasing Pao produced a progressive
decrease in patient comfort that wasd statistically sig-
nificant only between SB, FM and increased settings. In
fact, comfort was scored 8.9 ± 1.3 during SB and 7.7 ± 1.1,
7.5 ± 1.4, and 7.4 ± 1.8 at baseline settings during FM,
HS, and HN, respectively, whereas the scores were 6.4 ±
1.6 and 6.7 ± 1.6 at increased settings for HS and HN,
respectively. Group-mean differences between FM and
HS, FM and HN, SB and HS, SB and HN for comfort were
1.4 ± 1.1, 1.0 ± 1.4, 2.5 ± 1.3, and 2.2 ± 1.2, respectively.
Of note, there was no significant difference between the
interfaces on iso-assistance.
Table 1 presents the baseline data and Table 2 the data
following intervention at increased settings, with group-
mean differences between FM and SB versus HS and HN
presented as mean ± SD (see Table E1 in Additional file
1 in which data are presented as median (interquartiles)
in the appendix).Breathing pattern and inspiratory effort
An example of illustrative traces, that is, Pao, flow, Pes,
Pga, and Pdi recorded during the experimental trials, is
depicted in Figures 3 and 4.
Expiratory VT was lower, with FM, as opposed to all
other conditions. The differences in the respiratory rate
(RR) were small and not significant. Minute ventilation
(VE) significantly increased with HN at baseline settings
(P <0.0125) and with both helmets at increased settings
(P <0.0125) compared to FM.
Compared with SBI, NIV administered at baseline set-
tings did not modify inspiratory effort, as assessed by
pressure-time product of PTPdi/breath, PTPdi/min and
PTPdi/L, irrespective of the interface applied. HN at
increased settings performed better than FM in decreasing
inspiratory effort measured by PTPdi/breath (10.7 ± 9.9
versus 17.0 ± 11.0 cmH2O*s), PTPdi/min (128 ± 96 versus
204 ± 81 cmH2O*s/min), and PTPdi/L (12.6 ± 9.9 versus
30.2 ± 16.8 cmH2O*s/L). There was no significant dif-
ference in WOB irrespective of support level and type
of interface applied.Patient-ventilator synchrony
At baseline settings, Delay,TR-insp was significantly shorter
(P <0.0125) with FM (0.181 ± 0.086 s), compared to
both HS and HN (0.354 ± 0.081 s and 0.276 ± 0.091 s,
respectively). At increased settings, Delay,TR-insp was
shorter (P <0.0125) with HN (0.230 ± 0.061 s), compared
to HS (0.345 ± 0.073 s). With both HS and HN the
Table 1 Main ventilatory variables and inspiratory efforts at baseline
SBI Baseline settings SBE
FM HS HN
VT ml 787 ± 220 596 ± 147 794 ± 250 821 ± 240 842 ± 275
RRn breath/minute 13 ± 6 15 ± 7 14 ± 5 14 ± 5 14 ± 6
VE L/minute 9.6 ± 3.9 8.1 ± 2.3 10.2 ± 2.7 11.1 ± 4.9 10.7 ± 4.1
PTPdi/breath 20.0 ± 10.4 17.0 ± 11.0 16.6 ± 10.0 15.7 ± 10.7 17.4 ± 15.6
PTPdi/minute 241 ± 117 204 ± 81 201 ± 92 198 ± 109 190 ± 116
PTPdi/L 27.6 ± 15.5 30.2 ± 16.8 21.6 ± 10.5 20.9 ± 13.2 20.4 ± 14.8
WOB J/breath 0.456 ± 0.214 0.335 ± 0.142 0.400 ± 0.302 0.447 ± 0.309 0.460 ± 0.379
WOB J/minute 5.61 ± 2.71 4.54 ± 2.49 5.11 ± 3.00 6.60 ± 7.49 5.53 ± 3.98
WOB J/L 0.585 ± 0.206 0.525 ± 0.188 0.494 ± 0.172 0.569 ± 0.277 0.504 ± 0.274
Delay,TR-insp (s) NA 0.181 ± 0.086 0.354 ± 0.081 0.276 ± 0.091 NA
Delay,TR-exp (s) NA 0.275 ± 0.038 0.395 ± 0.093 0.301 ± 0.044 NA
TI,Synchrony (%) NA 90 ± 4 79 ± 7 83 ± 4 NA
Data are presented as mean ± SD. Baseline data; n = 12 healthy volunteers included. Baseline settings for FM, HS, HN: PEEP 5 cmH2O; PS 5 cmH2O, Ramp 0; Exp
trigger: 25%; FiO2: 21%. VT, tidal volume; VE, minute ventilation; RRn, neural respiratory rate; PTPdi, pressure-time product of the transdiaphragmatic pressure;
WOB, work of breathing; FM, face mask; HS, helmet standard; HN, helmet next; SBI, initial spontaneous breathing; SBE, end spontaneous breathing; PEEP, positive
end-expiratory pressure; PS, pressure support; Exp trigger, expiratory trigger; delay, TR-insp, inspiratory trigger delay; Delay,TR-exp, expiratory trigger delay; TI,Syn-
chrony, synchrony time as% of patient inspiratory time; NA, not applicable.
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ever, was not different to FM with HN only.
At baseline settings, Delay,TR-exp was similar between
FM (0.275 ± 0.038 s) and HN (0.301 ± 0.044 s), whereas for
HS (0.395 ± 0.093 s) it was significantly longer (P <0.0125).
Although at increased settings Delay,TR-exp slightly
improved with both HN (0.290 ± 0.099 s) and HS (0.367 ±Table 2 Main ventilatory variables and inspiratory effort follo
means differences between FM and SB versus HS and HN
Increased settings
HS HN F
VT ml 882 ± 276 853 ± 278 −28
RRn breath/minute 13 ± 4 14 ± 5 1.
VE L/minute 10.6 ± 3.0 11.6 ± 4.7 −2.
PTPdi/breath 13.0 ± 10.5 10.7 ± 9.9 4.0
PTPdi/minute 142 ± 80 128 ± 96 6.8
PTPdi/L 15.2 ± 10.0 12.6 ± 9.9 9.3
WOB J/breath 0.412 ± 0.313 0.390 ± 0.314 −0.1
WOB J/minute 5.04 ± 4.10 5.75 ± 5.79 −2
WOB J/L 0.448 ± 0.233 0.446 ± 0.267 0.0
Delay,TR-insp (s) 0.345 ± 0.073 0.230 ± 0.061 −0.1
Delay,TR-exp (s° 0.367 ± 0.074 0.290 ± 0.099 −0.0
TI,Synchrony (%) 80 ± 5 85 ± 2 9.8
Data are presented as mean ± SD and group mean differences ± SD. Data following
HN were PEEP 8 cmH2O; PS 8 cmH2O, Ramp 0; Exp trigger: 25%; FiO2: 21%. Data we
sures, *P <0.0125. VT, tidal volume; VE, minute ventilation; RRn, neural respiratory ra
of breathing; FM, face mask; HS, helmet standard; HN, helmet next; SBI, initial sponta
expiratory pressure; PS, pressure support; Exp trigger, expiratory trigger; delay, TR-in
chrony, synchrony time as% of patient inspiratory time; NA, not applicable.0.074 s), with the latter it remained significantly longer, as
opposed to FM.
Time of synchrony (TI,synchrony), expressed as per-
cent of patient’s inspiratory time, was longer during FM
(90 ± 4%), compared to HS (79 ± 7%) (P <0.0125) and HN
(83 ± 4%) at baseline settings. At increased settings, no
difference was found between helmets, but compared towing interventions, at increased settings, with group
Group mean difference (95% CI)
M-HS FM-HN SBI-HS SBI-HN
6 ± 338* −257 ± 320* −95 ± 219 −67 ± 222.
9 ± 4.5 0.42 ± 3.4 0.42 ± 3.4 −1.08 ± 3.3
7 ± 1.9* −3.6 ± 3.1* −1.0 ± 2.5 −2.0 ± 3.1
± 5.6* 6.3 ± 7.4* 7.0 ± 9.4* 9.4 ± 10.1*
± 93.2 75.6 ± 82.7* 44.2 ± 128.7* 113.1 ± 119.2*
± 14.5 17.6 ± 13.7* 6.7 ± 15.6 15.0 ± 14.7*
1 ± 0.33 −0.05 ± 0.35 0.01 ± 0.34 0.07 ± 0.33
.1 ± 5.9 −1.1 ± 4.6 −1.1 ± 5.6 −0.04 ± 4.0
2 ± 0.24 0.12 ± 0.25 0.06 ± 0.29 0.17 ± 0.30
6 ± 0.09 −0.05 ± 0.08 NA NA
9 ± 0.08 −0.02 ± 0.11 NA NA
± 5.9* 4.2 ± 4.1* NA NA
intervention; n = 12 healthy volunteers included. Increased settings for HS and
re analyzed with a generalized linear mixed-effects model for repeated mea-
te; PTPdi, pressure-time product of the transdiaphragmatic pressure; WOB, work
neous breathing; SBE, end spontaneous breathing; PEEP, positive end-
























SBI FM HS HS HN HN SBE
PEEP and PS 
5cmH2O
PEEP and PS 
8cmH2O
PEEP and PS 
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Figure 3 Representative traces of a patient (patient 1) during the randomized trials for spontaneous breathing, face mask at PEEP and
PS of 5 cmH2O, helmet standard at PEEP and PS of 5 cmH2O, helmet standard at PEEP and PS of 8 cmH2O, helmet next at PEEP and PS
of 5 cmH2O, helmet next at PEEP and PS of 8 cmH2O, and spontaneous breathing. Pao, Flow, Pes, Pga, and Pdi are shown from top to
bottom. FM, face mask; HN, helmet next; HS, helmet standard; Pao, pressure at the airway opening; Pdi, transdiaphragmatic pressure; PEEP, positive
end-expiratory pressure; Pe, esophageal pressure; Pga, gastric pressure; PS, pressure support.
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(80 ± 5%) and HN (85 ± 2%).
Discussion
We found that in healthy volunteers FM, HS and HN
at baseline settings, that is, PEEP 5 cmH2O and PS 5
cmH2O, were not significantly different with respect to
inspiratory muscles unloading, WOB and comfort. With
respect to patient-ventilator interaction, TI,synchrony
and Delay,TR-insp were significantly improved by FM
compared to both helmets, whereas Delay,TR-exp was
shorter with FM, as opposed to HS, but not HN. At in-
creased settings (that is, PEEP 8 cmH2O and PS 8 cmH2O),
inspiratory effort was significantly lower, compared to SBI
and FM, with HN, while not HS. Comfort was inversely
related to the pressure applied to the airway opening by















































Figure 4 The pressure-time product of the transdiaphragmatic pressu
per breath; (B) calculation per minute; (C) calculation per liter. FM: face ma
pressure; PS: pressure support; PTPdi: pressure-time product of the transdiasynchrony, as assessed by Delay,TR-insp and Delay,TR-
exp, was equivalent between FM at baseline setting and
HN at increased settings, but remained inferior with HS
even at increased settings. TI synchrony remained inferior
with both helmets at increased settings, compared to FM.
Before discussing our findings, some limitations of this
study merit consideration. First, our investigation was
conducted on healthy individuals, which makes our find-
ings not entirely inferable to the clinical setting. We share
this limit with several studies, some of which were
performed to evaluate HS at the time it was introduced
into clinical use [9,11,21]. As a matter of fact, studies on
HN are lacking, which justifies this first in vivo evaluation in
healthy volunteers. Second, of the seven trials performed
on each subject, the two spontaneous breathing trials and
four helmet trials had the same breathing apparatus with



























re calculated per breath, per minute, and per liter. (A) Calculation
sk; HN: helmet next; HS: helmet standard; PEEP: positive end-expiratory
phragmatic pressure; SB: spontaneous breathing.
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nose-clip, has been repeatedly shown to affect breathing
pattern by increasing VT and VE with few changes in the
RR [27,28]. In keeping with these studies, during the FM
trial VT and VE were smaller than during the other six
trials, the reduction in VE being statistically significant,
whereas the RR was only slightly decreased. As VT is
one of the variables, in addition to Pes, computed in the
measurement of WOB, the use of a breathing apparatus
might have influenced it to a similar extent. Third, we
limited the time of each trial to 5 minutes, which is
indeed rather short, especially when compared to that
utilized in other similar studies performed either in
healthy volunteers [9,21] or patients [10,12]. It should
be considered, however, that in contrast to these studies,
in our experimental set up the breathing apparatus was
connected to the subject through the mouthpiece, which
produces discomfort, potentially affecting either the
breathing pattern or the indexes of respiratory muscle
effort. Although we cannot exclude that the relatively
short period of evaluation could be not sufficient to
fully achieve a steady state, we are convinced that the
poor tolerance to the breathing apparatus would have
represented more bias. Finally, potential bias related to
the non-blinded setting of the study has to be taken
into consideration, although we share this limitation
with several studies [9,11,21].
In hypercapnic patients with severe chronic obstructive
pulmonary disease, Navalesi et al. observed a significant
decrease per minute in PTPdi of 65% and 43% with FM
and HS, respectively, as opposed to SB [10,12]. In patients
at high risk of developing post-extubation respiratory
failure, Vargas et al. found that at baseline settings, FM
and HS significantly reduced PTPdi per minute compared
to SB, at 69% and 60%, respectively [12]. In our healthy
volunteers, we also observed a reduction in PTPdi per
minute at baseline settings with respect to SB, but the
extent of this decrease range was lower (15 to 20%) and not
statistically significant, or significantly different between
the three interfaces. On one hand, these discrepancies
are likely a consequence of the lower inspiratory pressure
applied and on the other, due to the fact that in contrast
to the aforementioned studies [10,12], we performed our
investigation in normal subjects without underlying
respiratory disorders. Indeed, other previous studies on
healthy subjects at similar baseline settings also failed
to demonstrate a difference in PTPdi between FM and
HS [11], and between HS and SB [21]. In keeping with
Vargas et al., we found that at increased settings HS
and HN were both as effective as FM at the baseline
setting, in reducing inspiratory effort compared to SB;
of note, PTPdi expressed per breath, per minute or per
liter, was significantly lower with HN at increased settings
than with FM at baseline settings.Surprisingly, the differences in WOB between trials were
rather small and not significant. The large VT, that to some
extent was a consequence of the breathing apparatus
[27,28] as already mentioned, may have influenced this
variable, which is influenced by both Pes and VT. This may
also explain the lower, though not significantly lower
values of WOB/breath and WOB/minute observed during
the FM trial, in contrast to WOB/L, which, in fact was
not influenced by the amount of VT. A possible expiratory
activation of the expiratory respiratory muscles may
contribute to the better performance of both HS and
HN compared to the FM.
In agreement with previous work [10,12], at baseline
settings both Delay,TR-insp and Delay,TR-exp were
longer with HS than with FM, whereas with HN Delay,
TR-insp, but not Delay,TR-exp, was significantly higher,
with respect to FM. Whereas Vargas et al. found that
Delay,TR-insp with HS was significantly lower with the
increased settings than with the baseline settings, in our
study HS at increased settings compared to HS at baseline
settings did not produce significant improvements in
Delay,TR-insp, Delay,TR-exp or TI,synchrony, which all
remained worse than the corresponding values obtained
with FM at standard settings. Conversely, with HN the
increased settings improved all three variables, which were
not significantly different compared to FM at baseline.
HS was shown to be better tolerated than FM in studies
comparing the two interfaces over the medium (hours)
and long (days) period [7,8]. In the present investigation,
comfort was not influenced by the type of interface, as
already reported in the previous short term physiologic
investigations comparing FM and HS over brief periods
of time (20 to 30 minutes) [10,12], which has been
attributed to the longer time required for most of the
major determinants of patient discomfort during NIV
to take place [10,12]. Consistent with previous work on
healthy volunteers [21], however, we found that comfort
was affected by the amount of applied pressure.
Very recently, studies conducted either in hypoxemic
[15] and hypercapnic [16] patients, and a European survey
[17] on the use of NIV, indicate the rotational use of dif-
ferent interfaces as a possible means to improve patients’
tolerance and prolong NIV application. Our study shows
that different interfaces can be used to achieve comparable
results with respect to inspiratory effort reduction. In
addition, we found that in healthy volunteers, although FM
performs better overall than helmets at baseline settings, at
increased settings both helmets had improved performance
and resulted in lower inspiratory effort lower than SB
with both helmets, and even better than FM with HN
only. Furthermore, at increased settings HN achieved
better results for interaction and synchrony between
subject and ventilator compared to HS, which indicated
that this new interface performed similarly to FM.
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HN might hold some advantages compared to the other
interfaces with respect to interaction and synchrony but
studies on patients are needed to confirm these findings
in the clinical setting.
Key messages
 HN is a new interface that ameliorates its previous
standard version, HS, by reducing the pressure
dissipated because of the downward displacement of
the soft collar during ventilator insufflation, and by
avoiding the use of armpit braces.
 We found that NIV via an FM, HS and HN at
baseline settings, that is, PEEP 5 cmH2O and PS 5
cmH2O, were not significantly different with respect
to inspiratory muscles unloading, WOB and comfort
in healthy volunteers. With respect to patient-
ventilator interaction and inspiratory trigger delay
synchrony time and were significantly improved by
FM, compared to both helmets, whereas expiratory
trigger delay was also shorter with FM, as opposed
to HS, but not HN.
 At increased settings with HN (that is, PEEP 8
cmH2O and PS 8 cmH2O), inspiratory effort was
significantly lower compared to that obtained while
breathing spontaneously without assistance and FM.
Patient-ventilator synchrony, as assessed by inspiratory
trigger delay and expiratory trigger delay was
equivalent between FM at baseline setting and HN
at increased settings, but remained inferior with HS
even at increased settings.
Additional file
Additional file 1: Tables E1 and E2. An additional file in the appendix
contains two additional tables: Table E1 shows the main ventilatory
variables and inspiratory effort parameters obtained at baseline settings
and following interventions at increased settings, obtained in
spontaneous breathing (SB), facial mask (FM), standard helmet (HS) and
helmet next (HN) with data presented as median [interquartiles]; and
Table E2 shows the inspiratory and expiratory trigger delay and
synchrony time obtained at baseline settings and following interventions
at increased settings, obtained in facial mask (FM), standard helmet (HS)
and helmet next (HN) with data presented as median [interquartiles].
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